Co-Authors
This is a "connection" page, showing publications co-authored by Holger Rabenau and Annemarie Berger.
Connection Strength
0.709
-
Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs). J Virol Methods. 2021 05; 291:114102.
Score: 0.232
-
The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro. J Clin Med. 2021 Jan 17; 10(2).
Score: 0.231
-
Longitudinal Testing for Respiratory and Gastrointestinal Shedding of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Day Care Centers in Hesse, Germany. Clin Infect Dis. 2021 11 02; 73(9):e3036-e3041.
Score: 0.061
-
Typical symptoms of common otorhinolaryngological diseases may mask a SARS-CoV-2 infection. Eur Arch Otorhinolaryngol. 2021 Sep; 278(9):3551-3558.
Score: 0.058
-
Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020. Euro Surveill. 2020 06; 25(24).
Score: 0.055
-
Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. N Engl J Med. 2020 03 26; 382(13):1278-1280.
Score: 0.054
-
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003 May 15; 348(20):1967-76.
Score: 0.017